Latest Myeloma Research To Be Presented At The American Society Of Clinical...
The American Society of Clinical Oncology will hold its 49th annual meeting May 31 through June 4 in Chicago. Similar to previous years, more than 25,000 clinical specialists from all over the world...
View ArticleASCO 2013 Multiple Myeloma Update – Day Two: Education Session
Although this year’s annual meeting of the American Society of Clinical Oncology (ASCO) started last Friday, the first myeloma-related presentations at the meeting did not take place until Saturday...
View ArticleASCO 2013 Multiple Myeloma Update – Day Three: Poster Presentations
This year’s American Society of Clinical Oncology (ASCO) annual meeting, which is being held in Chicago, began on Friday and goes through Tuesday. Sunday started with a poster session in which...
View ArticleASCO 2013 Multiple Myeloma Update – Day Four: Oral Presentations
This year’s annual meeting of the American Society of Clinical Oncology (ASCO) came to an end yesterday in Chicago. Monday was the busiest day with regard to myeloma-related research. The day started...
View ArticleASCO 2013 Multiple Myeloma Update – Day Four: Poster Presentations
This year’s American Society of Clinical Oncology (ASCO), which was held in Chicago, began on Friday and concluded on Tuesday. Monday was the busiest day at the meeting with regard to myeloma research....
View ArticleASCO 2013 And Multiple Myeloma: What Were The Highlights?
This year’s meeting of the American Society of Clinical Oncology (ASCO) was held May 31 through June 4 in Chicago. During the meeting, The Beacon published daily updates that provided overviews of the...
View ArticleTwo New Studies Investigate The Significance Of Minimal Residual Disease In...
The results of two recent European studies provide new insights into minimal residual disease detection and its potential value in the treatment of multiple myeloma. The first study, carried out in...
View Article
